Head-to-head · WeighScore
Medsol RX vs Nova MD
The verdict
Nova MD takes it — 66.6/100 to 61/100.
Nova MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Nova MD is a telehealth platform offering compounded semaglutide and tirzepatide on 1-month and 3-month plans, with an uncommon explicit microdose program for both molecules.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Medsol RX | Nova MD |
|---|---|---|
| WeighScore | 61/100 | 66.6/100 |
| Grade | C | C |
| Scorecard rank | #306 | #187 |
| Semaglutide | $209/mo (compounded) | $175/mo (compounded) |
| Tirzepatide | $250/mo (compounded) | $225/mo (compounded) |
| Coverage | All 50 states | Coverage not published |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #306 · C
Strengths
- Compounded semaglutide from $209/mo (12-mo plan) and tirzepatide from ~$250/mo; HSA/FSA eligible with Klarna financing
- Every plan bundles the medication, a dedicated care coach, custom treatment plan, medical oversight, and free shipping
- Board-certified clinicians via OpenLoop; same-day approvals; ships nationwide
- Month-to-month option ($199 first month) with no long-term commitment, plus microdosing and wellness add-ons
Where it loses points
- Doesn't name its compounding pharmacy (generic 'certified U.S. pharmacies')
- No legal entity name published on the site
- Tirzepatide pricing is given as a range ($250-$1,400/mo), not a fixed rate
- Compounded GLP-1s are not FDA-approved (the site discloses this)
Graded #187 · C
Strengths
- On-page pricing published for all four SKUs (semaglutide and tirzepatide, 1- and 3-month)
- $125/mo semaglutide and $199/mo tirzepatide 3-month plans rank among the cheapest in the market
- $50 off first tirzepatide order shown publicly
- Explicit microdose / low-dose program for both semaglutide and tirzepatide
- Broader menu (sermorelin, NAD+, glutathione, enclomiphene) for longevity alongside GLP-1
Where it loses points
- Legal entity name and state of incorporation not disclosed
- Compounding pharmacy not named — only 'accredited facilities'
- LegitScript certification not confirmed (only 'Licensed US Providers' claims)
- Per-state availability not listed
- Compounded only — no brand-name Wegovy, Zepbound, Mounjaro, or Ozempic
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.